Search

everythinglearnresearchcommunity

for

Search:↓

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Some people with chronic hair loss may have thyroid autoimmunity.

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Autoimmune diseases like lupus, dermatomyositis, and scleroderma can cause hair loss and other hair problems, and treatments for these diseases might also affect hair.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Thyroid disorders are linked to skin issues and autoimmune skin diseases.

Accurate diagnosis of hair loss types is crucial for effective treatment.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.